Literature DB >> 26519341

Impact of Antidepressant Drugs on Sexual Function and Satisfaction.

David S Baldwin1,2,3,4, Chris Manson5, Magda Nowak5.   

Abstract

Pleasurable sexual activity is important in many human relationships and can provide a sense of physical, emotional and social well-being. Depressive symptoms and depressive illness are associated with impairments in sexual function and sexual dissatisfaction in untreated and treated patients. Most currently available antidepressant drugs are associated with development or worsening of sexual dysfunction in a substantial proportion of patients. Sexual difficulties during antidepressant treatment often resolve as depression lifts, but can persist over long periods, reducing self-esteem and affecting mood and relationships adversely. Sexual difficulties during antidepressant treatment typically have many possible causes but the incidence and nature of dysfunction varies between drugs. Many interventions can be considered when managing sexual dysfunction associated with antidepressants but no approach is 'ideal'. Because treatment-emergent sexual difficulties are less frequent with certain drugs, presumably related to differences in pharmacological properties, and since current interventions are suboptimal, a lower incidence of sexual dysfunction is a relevant tolerability target when developing novel antidepressants.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26519341     DOI: 10.1007/s40263-015-0294-3

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  105 in total

1.  Women's views of their sexual difficulties: agreement and disagreement with clinical diagnoses.

Authors:  Michael King; Victoria Holt; Irwin Nazareth
Journal:  Arch Sex Behav       Date:  2007-01-26

2.  Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitioner.

Authors:  S Read; M King; J Watson
Journal:  J Public Health Med       Date:  1997-12

Review 3.  Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis.

Authors:  Ursula Reichenpfader; Gerald Gartlehner; Laura C Morgan; Amy Greenblatt; Barbara Nussbaumer; Richard A Hansen; Megan Van Noord; Linda Lux; Bradley N Gaynes
Journal:  Drug Saf       Date:  2014-01       Impact factor: 5.606

4.  Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial.

Authors:  Revital Amiaz; Harrison G Pope; Thomas Mahne; John F Kelly; Brian P Brennan; Gen Kanayama; Mark Weiser; James I Hudson; Stuart N Seidman
Journal:  J Sex Marital Ther       Date:  2011

Review 5.  Bidirectional association between depression and sexual dysfunction: a systematic review and meta-analysis.

Authors:  Evan Atlantis; Thomas Sullivan
Journal:  J Sex Med       Date:  2012-03-29       Impact factor: 3.802

6.  Antidepressant treatment of premature ejaculation: discontinuation rates and prevalence of side effects for dapoxetine and paroxetine in a naturalistic setting.

Authors:  P Jern; A Johansson; J Piha; L Westberg; P Santtila
Journal:  Int J Impot Res       Date:  2014-11-20       Impact factor: 2.896

7.  Selective serotonin re-uptake inhibitor treatment-emergent sexual dysfunction: randomized double-blind placebo-controlled parallel-group fixed-dose study of a potential adjuvant compound, VML-670.

Authors:  David Baldwin; John Hutchison; Kirsteen Donaldson; Bob Shaw; Andrew Smithers
Journal:  J Psychopharmacol       Date:  2007-08-22       Impact factor: 4.153

Review 8.  Endothelial nitric oxide synthase regulation in female genital tract structures.

Authors:  Biljana Musicki; Tongyun Liu; Gwen A Lagoda; Trinity J Bivalacqua; Travis D Strong; Arthur L Burnett
Journal:  J Sex Med       Date:  2008-12-05       Impact factor: 3.802

Review 9.  Review: Bupropion and SSRI-induced side effects.

Authors:  K Demyttenaere; L Jaspers
Journal:  J Psychopharmacol       Date:  2008-02-28       Impact factor: 4.153

10.  Comparison of paroxetine and dapoxetine, a novel selective serotonin reuptake inhibitor in the treatment of premature ejaculation.

Authors:  Abdulmuttalip Simsek; Sinan Levent Kirecci; Onur Kucuktopcu; Faruk Ozgor; Mehmet Fatih Akbulut; Omer Sarilar; Unsal Ozkuvanci; Zafer Gokhan Gurbuz
Journal:  Asian J Androl       Date:  2014 Sep-Oct       Impact factor: 3.285

View more
  10 in total

Review 1.  Pharmacotherapy in Generalized Anxiety Disorder: Novel Experimental Medicine Models and Emerging Drug Targets.

Authors:  David S Baldwin; Ruihua Hou; Robert Gordon; Nathan T M Huneke; Matthew Garner
Journal:  CNS Drugs       Date:  2017-04       Impact factor: 5.749

2.  Acute caffeine reverses the disruptive effects of chronic fluoxetine on the sexual behavior of female and male rats.

Authors:  Brunella V González Cautela; Gonzalo R Quintana; Jessica Akerman; James G Pfaus
Journal:  Psychopharmacology (Berl)       Date:  2020-11-26       Impact factor: 4.530

Review 3.  Management Strategies for Antidepressant-Related Sexual Dysfunction: A Clinical Approach.

Authors:  Angel L Montejo; Nieves Prieto; Rubén de Alarcón; Nerea Casado-Espada; Javier de la Iglesia; Laura Montejo
Journal:  J Clin Med       Date:  2019-10-07       Impact factor: 4.241

4.  Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study.

Authors:  Gregory W Mattingly; Hongye Ren; Michael Cronquist Christensen; Martin A Katzman; Mircea Polosan; Kenneth Simonsen; Lene Hammer-Helmich
Journal:  Front Psychiatry       Date:  2022-03-09       Impact factor: 4.157

5.  Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice in Italy: Results from the RELIEVE Study.

Authors:  Sergio De Filippis; Anna Pugliese; Michael Cronquist Christensen; Gianluca Rosso; Marco Di Nicola; Kenneth Simonsen; Hongye Ren
Journal:  Neuropsychiatr Dis Treat       Date:  2022-08-09       Impact factor: 2.989

Review 6.  Behavioral, Neural, and Molecular Mechanisms of Conditioned Mate Preference: The Role of Opioids and First Experiences of Sexual Reward.

Authors:  Gonzalo R Quintana; Conall E Mac Cionnaith; James G Pfaus
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

7.  Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice: French Cohort Results from the Global RELIEVE Study.

Authors:  Mircea Polosan; Marc Rabbani; Michael Cronquist Christensen; Kenneth Simonsen; Hongye Ren
Journal:  Neuropsychiatr Dis Treat       Date:  2022-08-31       Impact factor: 2.989

8.  What is the "weight" of body mass index on sexual functioning in women? A mediation model.

Authors:  Maria Di Nardo; Chiara Conti; Giulia Di Francesco; Giulia Nicolardi; Maria Teresa Guagnano; Piero Porcelli
Journal:  Eat Weight Disord       Date:  2020-09-12       Impact factor: 4.652

Review 9.  Assessment and management of sexual dysfunction in the context of depression.

Authors:  Pratap R Chokka; Jeffrey R Hankey
Journal:  Ther Adv Psychopharmacol       Date:  2017-07-31

10.  Enjoyment of Sexuality and Longevity in Late Midlife and Older Adults: The Longitudinal Ageing Study Amsterdam.

Authors:  Shanice Beerepoot; Suzanne W M Luesken; Martijn Huisman; Dorly J H Deeg
Journal:  J Appl Gerontol       Date:  2022-03-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.